Pentagon turmoil and psychedelics boom: what Trump’s moves could mean for US security and markets

The cluster centers on two fast-moving US developments with potential spillovers into national security governance and capital markets. First, The Wall Street Journal reports that a public dispute between US Defense Secretary Pete Hegseth and Army Secretary Mark Driscoll has spilled beyond internal offices, raising questions about civil-military cohesion at the Pentagon. Second, TASS relays the WSJ’s claim that Hegseth is worried Donald Trump could be looking at Driscoll as a replacement, after a March 2025 revelation that Hegseth allegedly posted classified war plans in a Signal chat with senior national-security aides. In parallel, war.gov states that President Trump signed the Small Business Innovation and Economic Security Act, prompting the War Department to redesign and refocus Small Business Innovation Research and technology transfer initiatives to accelerate delivery of advanced capabilities to the warfighter. Strategically, the Pentagon leadership friction matters because it touches the credibility of US decision-making during a period when defense innovation and personnel stability are both critical. If the alleged classified-information breach narrative gains traction, it could shift internal power dynamics, intensify scrutiny of information handling, and create incentives for tighter compartmentalization across the defense bureaucracy. The reported Trump-Driscoll replacement concern signals that the White House may be willing to recalibrate senior military leadership, which can affect procurement priorities, risk tolerance, and inter-service coordination. Meanwhile, the Small Business Innovation and Economic Security Act framing links defense modernization to economic security, suggesting a policy push to broaden the defense industrial base and speed technology maturation. On the markets side, Bloomberg and MarketWatch describe a surge in psychedelic-related stocks after Trump signed an executive order to expedite research and access, particularly for mental-health indications. The immediate premarket rally implies heightened investor expectations for faster regulatory pathways, potentially compressing timelines for clinical development and approvals. While the articles do not name specific tickers, the direction is unambiguously upward for the sector, with momentum likely to spill into biotech and specialty pharma sentiment. The combined picture—defense innovation acceleration plus a regulatory easing for psychedelics—could also influence risk appetite toward policy-sensitive growth themes, where executive-branch actions can rapidly reprice regulatory and commercialization probabilities. What to watch next is whether the Pentagon dispute escalates into formal personnel actions, congressional scrutiny, or security-policy changes tied to the Signal-chat allegation. Key indicators include any confirmation of leadership reshuffles, changes in classified information handling procedures, and signals from the Pentagon and Army about internal coordination mechanisms. For the psychedelics trade, investors should monitor the executive order’s implementing guidance, agency timelines for research and regulatory review, and any early signals of how mental-health drug pathways will be operationalized. A practical trigger point for escalation would be additional reporting that substantiates the classified-plans claim or prompts investigations, while de-escalation would look like quiet stabilization of leadership roles and clear compliance messaging. Near-term market sensitivity will likely remain high through the next regulatory milestones and any follow-on announcements from the War Department on the redesigned innovation and technology transfer programs.

Geopolitical Implications

• 01

  Civil-military cohesion risk at the Pentagon could affect US defense modernization execution and inter-service coordination.

• 02

  If classified-information allegations lead to formal scrutiny, it may tighten information handling and reshape internal power dynamics within the national security apparatus.

• 03

  White House willingness to recalibrate senior military leadership signals a more interventionist personnel posture, with potential downstream effects on procurement priorities.

• 04

  Linking defense innovation to economic security suggests a broader strategy to accelerate technology maturation through the broader industrial base, potentially affecting competition with strategic rivals.

Key Signals

• —Any official or credible reporting on investigations or security-policy changes related to the alleged Signal-chat classified plans.
• —Announcements or leaks about Pentagon/Army leadership changes, reporting lines, or changes in decision authority.
• —Implementation details and agency timelines for the executive order on psychedelic research and access.
• —War Department guidance on the redesigned SBIR and technology transfer program scope, funding, and delivery milestones.